Nexgel (NXGL) Current Deferred Revenue (2020 - 2025)
Historic Current Deferred Revenue for Nexgel (NXGL) over the last 5 years, with Q3 2025 value amounting to $180000.0.
- Nexgel's Current Deferred Revenue rose 55.87% to $180000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $180000.0, marking a year-over-year increase of 55.87%. This contributed to the annual value of $179000.0 for FY2024, which is 79500.0% up from last year.
- Latest data reveals that Nexgel reported Current Deferred Revenue of $180000.0 as of Q3 2025, which was up 55.87% from $180000.0 recorded in Q2 2025.
- In the past 5 years, Nexgel's Current Deferred Revenue registered a high of $286000.0 during Q1 2025, and its lowest value of $20000.0 during Q4 2023.
- Over the past 4 years, Nexgel's median Current Deferred Revenue value was $179000.0 (recorded in 2024), while the average stood at $152500.0.
- As far as peak fluctuations go, Nexgel's Current Deferred Revenue soared by 79500.0% in 2024, and later soared by 55.87% in 2025.
- Nexgel's Current Deferred Revenue (Quarter) stood at $38000.0 in 2021, then tumbled by 47.37% to $20000.0 in 2023, then skyrocketed by 795.0% to $179000.0 in 2024, then grew by 0.56% to $180000.0 in 2025.
- Its Current Deferred Revenue stands at $180000.0 for Q3 2025, versus $180000.0 for Q2 2025 and $286000.0 for Q1 2025.